Navellier & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,311	Closed	-$821K	–	300
2018 Q3	$821K	Buy	16,311 +410	+3%	+$20.6K	0.11%	163
2018 Q2	$952K	Buy	+15,901	New	+$952K	0.13%	149